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n 
 
Xenopus
 
 oocytes, the spindle assembly checkpoint
(SAC) kinase Bub1 is required for cytostatic factor
(CSF)-induced metaphase arrest in meiosis II. To in-
vestigate whether matured mouse oocytes are kept in
metaphase by a SAC-mediated inhibition of the ana-
phase-promoting complex/cyclosome (APC/C) complex,
we injected a dominant-negative Bub1 mutant (Bub1dn)
into mouse oocytes undergoing meiosis in vitro. Passage
through meiosis I was accelerated, but even though the
SAC was disrupted, injected oocytes still arrested at
metaphase II. Bub1dn-injected oocytes released from CSF
I
 
and treated with nocodazole to disrupt the second mei-
otic spindle proceeded into interphase, whereas nonin-
jected control oocytes remained arrested at metaphase.
Similar results were obtained using dominant-negative
forms of Mad2 and BubR1, as well as checkpoint resis-
tant dominant APC/C activating forms of Cdc20. Thus,
SAC proteins are required for checkpoint functions in
meiosis I and II, but, in contrast to frog eggs, the SAC is
not required for establishing or maintaining the CSF ar-
rest in mouse oocytes.
 
Introduction
 
After mitotic expansion of diploid germ cells, oocytes enter
meiotic differentiation, which is a discontinuous two-step
process. After initiation of meiosis, oocytes become arrested in
prophase of meiosis I, where oocytes continue to grow until
progesterone triggers the completion of meiosis I and entry into
meiosis II. Matured oocytes are arrested at metaphase of meiosis
II and await fertilization, which completes the meiotic process.
Investigating the nature of this arrest in meiosis II, Masui
and Markert (1971) discovered that microinjection of a cyto-
plasmic extract from metaphase II arrested frog eggs into one
blastomere of a two cell stage embryo caused a cleavage arrest
in the injected blastomere, whereas the uninjected blastomere
continued to divide normally. This activity was called cyto-
static factor (CSF). The same extracts, when injected into im-
mature oocytes, which are arrested in the prophase of first
meiosis, could induce the resumption and completion of the
meiotic maturation process. This second activity was called
maturation promoting factor (MPF). Later, the Mos–MAPK
pathway was identified as CSF (Sagata et al., 1989), and a
complex of Cdk1–cyclin B as MPF (Dunphy et al., 1988;
Gautier et al., 1988; Lohka et al., 1988). Both, Mos–MAPK
and Cdk1–cyclin B activities are low in prophase/germinal
vesicle (GV) stage oocytes, are stimulated by the resumption
of the meiotic process and are high at GV breakdown
(GVBD), which marks the entry into meiotic maturation. MPF
activity drops between the first and the second meiosis,
whereas the Mos–MAPK pathway is active throughout meiosis.
Upon fertilization, both activities drop and meiosis II is
completed with the extrusion of the second polar body (PB;
Tunquist and Maller, 2003).
The role of the Mos–MAPK pathway in meiosis has been
extensively studied in 
 
Xenopus
 
 eggs. In this system, the MAP-
KKK Mos performs several roles, i.e., initiation of GVBD
(Sagata et al., 1988; Yew et al., 1992), suppression of S-phase
between the first and the second M-phase (Furuno et al., 1994),
as well as the CSF arrest (Sagata et al., 1989). In mouse oocytes,
Mos is synthesized around GVBD, and, as in the frog, MAPK
is active throughout meiosis (Verlhac et al., 1996). To check,
whether Mos is essential for meiosis in mouse oocytes, knock-
out mice were generated (Colledge et al., 1994; Hashimoto et
al., 1994). Mos-deficient mice were viable, but females were
subfertile due to defects in oocyte maturation. Their oocytes
became frequently parthenogenetically activated and extruded
the second PB, indicating an essential role for Mos in the meiosis
 
Correspondence to Chizuko Tsurumi: tsurumi@immunbio.mpg.de
Abbreviations used in this paper: APC/C, anaphase-promoting complex/cyclo-
some; CSF, cytostatic factor; GV, germinal vesicle; GVBD, GV breakdown;
MPF, maturation promoting factor; PB, polar body; PI, propidium iodide; SAC,
spindle assembly checkpoint. 
JCB • VOLUME 167 • NUMBER 6 • 2004 1038
 
II arrest of mouse oocytes. In contrast to frog oocytes, how-
ever, Mos-deficient oocytes were still able to suppress DNA
replication between meiosis I and II, as well as after meiosis II.
Careful analysis of the Mos-deficient oocytes revealed that, af-
ter the extrusion of the second PB, the parthenogenetically acti-
vated eggs did not exit M-phase, but stayed in a metaphase-like
state. This third metaphase is thought to be mediated by the
spindle assembly checkpoint (SAC), induced by the haploid
genome (Verlhac et al., 1996).
How DNA replication is suppressed between meiosis I
and II, and how Mos arrests cells at metaphase of meiosis II are
important, yet still unresolved, issues. Studies using 
 
Xenopus
 
egg extracts identified several factors required for CSF activity,
including Cdk2/cyclin E (Tunquist et al., 2002), RINGO (Ferby
et al., 1999), Emi1 (Reimann and Jackson, 2002), and Bub1
(Tunquist et al., 2002). Among those factors, a direct connection
to the MAPK pathway has only been postulated for the Bub1 ki-
nase, which is a SAC component that was shown to be phos-
phorylated in vitro by p90
 
Rsk
 
, a downstream target of MAPK
(Schwab et al., 2001). Bub1 might thus be a link between CSF
and the SAC, suggesting that components of the SAC might be
recruited to generate the arrest of mature oocytes at metaphase
of meiosis II in 
 
Xenopus
 
 eggs (Tunquist et al., 2002, 2003).
During mitosis, the SAC senses the proper attachment of
chromosomes to the spindle apparatus, delaying sister chroma-
tid separation and exit from mitosis until all kinetochores are
properly attached in a bipolar manner (Musacchio and Hard-
wick, 2002; Yu, 2002). The molecular components of the SAC
were first discovered in yeast genetic screens, which identified
Mad1, 2, and 3 (BubR1), as well as Bub1-3 and Mps1 as essen-
tial components (Hoyt et al., 1991; Li and Murray, 1991; Weiss
and Winey, 1996). With the exception of Bub2, these proteins
are conserved in eukaryotes and generally required for the
SAC. In contrast to budding yeast, however, the mitotic check-
point is essential for proper progression through mitosis in
multicellular organisms (Dobles et al., 2000).
Mad1, Mad2, BubR1, Bub1, and Bub3 localize to the ki-
netochores of unaligned chromosomes, generating the inhibitory
signal that delays the onset of anaphase (Basu et al., 1998; Chen
et al., 1996; Li and Benezra, 1996; Taylor and McKeon, 1997;
Taylor et al., 1998; Chan et al., 1999). Bub1 and BubR1 are pro-
tein kinases, which both interact with Bub3 (Taylor et al., 1998).
BubR1 interacts with CENP-E (Chan et al., 1998), which senses
spindle tension at the kinetochores, and Cdc20, thereby inhibit-
ing the anaphase-promoting complex/cyclosome (APC/C; Tang
et al., 2001). Bub1 is required for the recruitment of other pro-
teins to the kinetochores and was proposed to work as a scaf-
folding protein (Sharp-Baker and Chen, 2001; Musacchio and
Hardwick, 2002). Once the checkpoint is activated, Bub1 also
interacts with Mad1, which is required for the kinetochore local-
ization of Mad2 and the formation of the Mad2-Cdc20 complex
(Luo et al., 2002). The localization of these proteins to the kine-
tochore is thus interdependent and disruption of one protein is
often enough to cause checkpoint defects in cells. However, it is
not yet clear whether the SAC components act in a single or in
multiple pathways, responding to microtubule attachment at ki-
netochores, or interkinetochore tension caused by bipolar at-
tachment to the mitotic spindle, respectively (Musacchio and
Hardwick, 2002; Yu, 2002; Zhou et al., 2002).
Little is known about a potential involvement of the SAC
in the CSF arrest of mouse oocytes. Mad2 and Bub1 localize to
kinetochores in metaphase II arrested oocytes, supporting a po-
tential role of the SAC in CSF (Kallio et al., 2000; Brunet et al.,
2003). Moreover, a Mad2-dependent checkpoint is functional
during meiosis I (Wassmann et al., 2003). SAC components are
thus present and can be activated during the meiotic maturation
of mouse oocytes. Here, we tested the involvement of several
SAC proteins in CSF by injecting dominant-negative interfer-
ing mutants of checkpoint proteins (Bub1, Mad2, and BubR1),
or gain of function mutants of the APC/C activator Cdc20, into
mouse oocytes. We present evidence that, although these pro-
teins disrupt the SAC in meiosis I and II, they do not abrogate
the CSF-induced metaphase II arrest.
 
Results
 
The effect of dominant-negative Bub1 
(Bub1dn) on meiosis I and II
 
To check whether the SAC is involved in the CSF-mediated
metaphase II arrest in mouse oocytes, we chose to microinject
interfering mutants of SAC components into oocytes. GV stage
(prophase I) oocytes were injected with in vitro transcribed and
Figure 1. Overview of the oocyte injection
experiments. MI, AI, and TI indicate metaphase,
anaphase, and telophase of meiosis I, respec-
tively. IK, interkinasis; MII, metaphase of meo-
sis II. Time after GVBD is indicated in hours. 
CSF IN MOUSE OOCYTES • TSURUMI ET AL.
 
1039
 
capped mRNAs encoding the mutant protein, kept in prophase
for 1 h by medium containing dbcAMP, and subsequently re-
leased for completion of meiosis by exchanging the medium.
Resumption of meiotic maturation can be monitored because
the oocytes dissolve their nuclear membrane (GVBD) 60–90
min after the release. The first meiotic division, which results
in the extrusion of a PB, takes place 9–10 h after GVBD. Oo-
cytes then enter meiosis II without an intermittent S phase, and
become arrested at metaphase of meiosis II, by the activity of
CSF. This metaphase II arrest is stable for more than 15 h in
our in vitro culture system (see Fig. 1 for a schematical repre-
sentation of our experimental set up).
A YFP-fusion protein of a dominant-negative version of
Bub1 (Bub1dn, amino acids 1–331) was used to test whether
Bub1 is required for the metaphase II arrest in mouse oo-
cytes. This mutant lacks the kinase domain, and disrupts the
SAC in somatic cells by competing with the endogenous ki-
nase for kinetochore localization. When microinjected into
mouse oocytes, the fusion protein localized to kinetochores
during meiosis (Fig. 2).
Because the localization of Bub1dn-YFP to kinetochores
might enable it to interfere with Bub1 function during meiosis,
we microinjected the mRNA encoding Bub1dn into prophase
oocytes, and monitored progression through meiosis. Time-
lapse video microscopy (Fig. 3 A) revealed that most of the
Bub1dn mRNA injected oocytes extruded their first PB 3 h ear-
lier (i.e., 6–7 h after GVBD) than non- or control-injected oo-
cytes (Table I). Thus, the Bub1dn mutant accelerated progres-
sion through meiosis I, probably by interfering with the SAC.
To check the effects of Bub1dn on CSF and meiosis II,
injected as well as noninjected control oocytes were cultured
overnight, and stained for DNA (propidium iodide [PI] or
DAPI) and, in some cases, tubulin to visualize the meiotic spin-
dle apparatus. Both, untreated as well as Bub1dn injected oo-
cytes arrested at metaphase II, with condensed chromosomes
and well organized meiotic spindles (Fig. 3 B, a–c and d–f, 1st
column; Table II).
To examine, whether Bub1dn interferes with the SAC in
meiosis II, oocytes were treated with strontium to inactivate
CSF in the presence or absence of nocodazole. Strontium
treatment caused Bub1dn as well as control-injected oocytes
Figure 2. Localization of Bub1dn-YFP on
kinetochores. Bub1dn-YFP and histone H2B-
RFP mRNAs were coinjected into GV-stage
oocytes, kept in dbcAMP for 1 h, released,
and fixed 5–6 h after GVBD (1st meiosis) or
overnight culture (2nd meiosis). (Left) The
whole oocyte is shown in an overview, with
chromosomes in red (histone H2B-RFP) and
Bub1dn-YFP in green. The position of the PB
is marked. (Right) Chromosomes are en-
larged, and the signals from histone H2B-RFP
and Bub1dn-YFP individually, as well as over-
laid (merge). Note the dotted appearance of
the Bub1dn-YFP signal around the chromo-
somes suggesting a kinetochore localization.
Bar, 10  m.
 
Table I. 
 
Timing of PB extrusion of oocytes injected with constructs 
encoding mutant checkpoint proteins (time-lapse video)
Uninjected Bub1dn BubR1d Mad2
 
 
 
C Cdc20-GR Cdc20-4AV
Cdc20-
4AVGR
 
5
 
a
 
03 003 03
6 0 13 1 1 11 0 8
7 0 16 10 11 10 8 6
80 0 8 9 1 11 5 3
90 2 2 1 1 10
10 20 0 0 0 0 0 0
11 9 0 0 0 0 0 0
12 4 0 0 0 0 0 0
Total 33/47
 
b
 
34/35 21/22 22/28 36/53 24/27 20/32
 
a
 
Hours after GVBD.
 
b
 
No. of oocytes with PB extruded/total oocytes.
 
Table II. 
 
MI/MII arrest of oocytes injected with constructs encoding 
mutant checkpoint proteins
Uninjected Bub1dn BubR1d Mad2
 
 
 
C
Cdc20-
GR
Cdc20-
4AV
Cdc20-
4AVGR
 
n
 
 
 
 
 
 32
 
n
 
 
 
 
 
 125
 
n
 
 
 
 
 
 100
 
n
 
 
 
 
 
 128
 
n
 
 
 
 
 
 53
 
n
 
 
 
 
 
 60
 
n
 
 
 
 
 
 160
 
%% % % % % %
 
No PB (MI) 3 25 17 15 17 18 49
PB (MII) 97 75 83 85 83 82 51 
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to exit from the CSF arrest, as indicated by the decondensa-
tion of the chromatin and the formation of anaphase spindles
(Fig. 3 B, 2nd column). Nocodazole treatment alone produced
highly condensed chromosomes with no visible spindles in
both injected and noninjected oocytes (Fig. 3 B, 3rd column).
In contrast to nocodazole-treated control oocytes, which re-
mained arrested with highly condensed chromosomes in the
presence of strontium, Bub1dn-injected oocytes were released
from the metaphase arrest (Fig. 3 B, compare 4th column a–c
with d–f; Table III). Thus, Bub1dn is capable of abrogating
the SAC in meiosis II.
To make sure that Bub1dn-treated oocytes were really ar-
rested at metaphase II, we measured the kinase activities of
MPF and MAPK, as a downstream target of CSF, from individ-
ual oocytes 22 h after GVBD. There was no difference in ki-
nase activity between uninjected and Bub1dn-injected mature
oocytes (Fig. 3 C), confirming that Bub1dn did not interfere
with the CSF arrest.
These results suggested that the SAC induced by nocoda-
zole is able to prevent oocytes from exiting meiosis even if
CSF is inactivated. Disruption of the SAC by using dominant-
negative Bub1, on the other hand, was not sufficient to allow
exit from the CSF arrest.
 
Mad2
 
 
 
C and BubR1dn disrupt the SAC 
but not CSF
 
Recent studies indicated that the SAC might consist of individ-
ual branches, with Bub1 playing an important role in only one
of them (Musacchio and Hardwick, 2002; Yu, 2002). There-
fore, it is possible that CSF uses the other pathways that in-
clude Mad2 or/and BubR1. To test whether Mad2 or BubR1
are involved in CSF signaling in mouse oocytes, we made use
of two previously described dominant-negative mutants of
these two proteins, Mad2
 
 
 
C and BubR1d. Mad2
 
 
 
C lacks 10
aa at the COOH terminus of the protein and cannot interact
with Cdc20 (Luo et al., 2002). BubR1d (BubR1 351-700) can
Figure 3. The effect of Bub1dn injection on meiosis I and II in mouse oocytes. (A) Time-lapse video microscopy. Uninjected, and Bub1dn-injected oocytes
were kept 1 h in dbcAMP before they were released from the prophase block. 3 h after GVBD, the oocytes were placed under the microscope in a 37 C
heating box. Pictures were taken every 45 min for 12 h. Red arrows indicate the extruded PB. Time points (h) after GVBD are indicated. Bar, 50  m.
(B) Bub1dn disrupts the SAC in meiosis II. Uninjected, and Bub1dn-injected oocytes were cultured for 14–15 h after GVBD and transferred into individual
drops of medium containing nocodazole, or strontium, or both, and then cultured for an additional 3–4 h. Oocytes were fixed and stained with PI (red)
and an anti-tubulin antibody, followed by an FITC-labeled secondary antibody (green; a and d), or with DAPI alone (b and e). The position of the PB is
marked, and the oocyte chromosomes are boxed. (c and f) The DAPI stained chromosomes from b and e were enlarged by 2.6 times. Bar, 10  m. (C) Single
cell H1/MBP kinase assay. Total H1 and MBP kinase activities were assayed in whole cell lysates prepared from uninjected, GV-stage, and Bub1dn-
injected oocytes. The autoradiograph is shown.
 
Table III. 
 
SAC analysis in meiosis II
Uninjected Bub1dn BubR1d Mad2
 
 
 
C Cdc20-4AVGR
 
Untreated 0/4
 
a
 
 (0%) 0/3 (0%) 0/2 (0%) 0/2 (0%) See Table IV
Strontium 23/28 (82%) 18/19 (95%) 8/8 (100%) 11/13 (85%) 21/22 (95%)
Nocodazole 0/14 (0%) 0/22 (0%) 0/18 (0%) 0/24 (0%) 0/4 (0%)
Strontium 
 
  
 
nocodazole 0/20 (0%) 24/28 (85%) 21/28 (75%) 19/21 (90%) 10/14 (71%)
 
a
 
No. of oocytes released from CSF/total oocytes. 
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bind Bub3 and Cdc20, but cannot inhibit APC/C in vitro, and
overexpressed BubR1d was shown to act as a dominant nega-
tive in human cells (Tang et al., 2001).
In time course experiments, overexpression of either
Mad2
 
 
 
C or BubR1d accelerated passage of the oocytes
through meiosis I, when compared with uninjected controls
Figure 4. The effect of Mad2 C and BubR1d injection on meiosis I and II in mouse oocytes. (A) Time-lapse video microscopy. Mad2 C or BubR1d injected
oocytes were treated as in Fig. 3 A. Pictures were taken every 30 min for 12 h. Red arrows indicate the extruded PB. Time points (h) after GVBD are
indicated. Bar, 50  m. (B) Immunofluorescence staining of Mad2 C (left) or BubR1d-injected (right) oocytes. Mad2 C or BubR1d-injected oocytes were
kept 1 h in dbcAMP before they were released from the prophase block. 20 h after GVBD, the oocytes were fixed, chromosomes stained with PI (red), and
the meiotic spindles visualized using an anti-tubulin antibody, followed by an FITC-labeled secondary antibody (green). Note the extruded PB, and the
chromosomes aligned on a metaphase plate with an intact spindle apparatus, indicating a CSF-arrest. Bar, 10  m. (C) Activation of Mad2 C and
BubR1d-injected oocytes. Uninjected, and Mad2 C- or BubR1d-injected oocytes were cultured for 14–15 h after GVBD and transferred into individual
drops of medium containing nocodazole, or strontium, or both, and then cultured for an additional 3–4 h. Chromosomes were stained with DAPI. The position
of the PB is marked. The oocyte nuclei are boxed, and shown enlarged in the insets. Bar, 10  m. 
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(Fig. 4 A; Table I). But, as with the Bub1dn mutant, neither
construct was able to overcome CSF and induce exit from the
metaphase II arrest. The spindle apparatus as well as the con-
densed metaphase chromosomes were similar to the control
CSF-arrested oocytes (Fig. 4 B). Again, as with Bub1dn, the
injected proteins were functional in abolishing the SAC, be-
cause they allowed metaphase II-arrested oocytes to proceed to
interphase when released from the CSF in the presence of no-
codazole (Fig. 4 C; Table III). Together, these results strongly
argue against an essential role of the SAC in the CSF-mediated
metaphase II arrest in mouse oocytes.
 
Cdc20 overexpression cannot override 
CSF
 
The above results argue against a role of SAC proteins in the
CSF-mediated meiosis II arrest in mouse oocytes. However,
they rely on dominant-negative mutants that may only abro-
gate the SAC, but not a potential CSF function of the en-
dogenous proteins. Also, the CSF might still inhibit the
APC/C by directly inactivating Cdc20. To test whether Cdc20
might be rate limiting for APC/C activation in CSF-arrested
mouse oocytes, we checked whether overexpression of mouse
Cdc20 would override the CSF arrest as has been shown
before in the 
 
Xenopus
 
 egg system (Reimann and Jackson,
2002).
First, we expressed YFP-tagged Cdc20 to monitor its
subcellular localization in mouse oocytes. Cdc20-YFP local-
ized strongly to kinetochores, and, more pronounced in meiosis
II than in meiosis I, to spindles (Fig. 5). Other than in mitotic
cells, Cdc20-YFP did not localize to the spindle poles.
Despite correct localization, overexpression of Cdc20-YFP
did not overcome the CSF-mediated metaphase II arrest in mouse
oocytes. To exclude the possibility that the COOH-terminal YFP
tag might have interfered with Cdc20 function, we also expressed
untagged wild-type Cdc20 in mouse oocytes (unpublished data).
In contrast to frog eggs, however, overexpression of Cdc20 did
not interfere with the CSF arrest in the injected mouse oocytes.
 
Dominant checkpoint-resistant forms of 
Cdc20 do not override the CSF arrest
 
Although consistent with the results from the experiments using
dominant-negative checkpoint proteins, the failure of Cdc20
overexpression to overcome the CSF arrest might be due to in-
sufficient expression levels, or efficient inactivation of Cdc20.
To overcome these limitations, we made use of a gain of function
mutant of Cdc20, which harbors mutations in one of its WD40
repeats (Cdc20-50 or Cdc20-GR; Schott and Hoyt, 1998). We in-
troduced the GR mutation into mouse Cdc20, to test whether this
potentially checkpoint-resistant Cdc20 mutant might be capable
of overcoming the CSF arrest in mouse oocytes.
Figure 5. Localization of Cdc20-YFP. Cdc20-
YFP and histone H2B-RFP were coinjected into
GV-stage oocytes, kept in dbcAMP for 1 h, re-
leased and fixed 6 h after GVBD (1st meiosis),
9–10 h after GVBD (1st anaphase and 1st
telophase), or after overnight culture (2nd
meiosis). (Left) The whole oocyte is shown in
an overview, with chromosomes in red (histone
H2B-RFP) and Cdc20-YFP in green. The posi-
tion of the PB is marked in the metaphase II-
arrested  oocytes. (Right) The chromosomes
are enlarged, and the signals from histone
H2B-RFP and Cdc20-YFP are shown individu-
ally, as well as overlaid (merge). Bars, 10  m. 
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Figure 6. The effect of Cdc20-GR and -4AV injection into mouse oocytes. (A) Time-lapse video microscopy. Uninjected, or oocytes injected with
Cdc20-GR or -4AV were treated as in Fig. 3 A. Red arrows indicate the extruded PB. Time points (h) after GVBD are indicated. Bar, 50  m. (B) Immu-
nofluorescence staining of control (left), or Cdc20-GR injected (middle), or Cdc20-4AV injected (right) oocytes. Oocytes were treated as in Fig. 4 B. Note
the extruded PB, and the chromosomes aligned on a metaphase plate with an intact spindle apparatus. (C) The localization of Cdc20 is affected by check-
point protein mutants. Cdc20-YFP and histone H2B-RFP mRNA and Bub1dn- or Mad2 C- or BubR1d-injected oocytes were treated as above, and fixed
5–6 h (1st meiosis) after GVBD, or after overnight culture (2nd meiosis). The histone H2B-RFP and Cdc20-YFP signals are shown individually, as well as
overlaid (merge). Note the dotted appearance of the Cdc20-YFP signal around the chromosomes, suggesting a kinetochore localization, in the Mad2 C
coinjected oocytes, which is weaker in the BubR1d coinjected, and seems absent from the Bub1dn coinjected oocytes. (D) The localization of the Cdc20-GR
or -4AV YFP-fusion proteins. Cdc20-GR-YFP– or Cdc20-4AV-YFP– and H2B-RFP–injected oocytes were treated as above, and fixed 6 h (1st meiosis) after
GVBD, or after overnight culture (2nd meiosis). Note the dotted appearance of the Cdc20-4AV-YFP signal around the chromosomes, suggesting a kineto-
chore localization, which is not detectable in Cdc20-GR-YFP–injected oocytes. Bars: (B–D) 10  m. 
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As shown in Fig. 6, the Cdc20-GR mutant caused early
anaphase in the first meiosis (Fig. 6 A; Table I), but could
not force exit from metaphase II (Fig. 6 B; Table II). This
mutant, thus, behaved similarly to the above tested dominant-
negative checkpoint proteins, and could, despite its check-
point resistance, not activate the APC/C to induce exit from
meiosis II.
Chung and Chen (2003) found that the mutation of 4 pu-
tative CDK or MAPK phosphorylation sites in Cdc20 to non-
phosphorylatable amino acids (Cdc20-4AV) generated a domi-
nant Cdc20 that was capable of overriding the SAC, as well as
CSF, in the 
 
Xenopus
 
 egg extract. Thus, CSF might inhibit
Cdc20 by phosphorylation. To test this hypothesis, we pro-
duced a mouse version of Cdc20-4AV.
Injection of this mutant into mouse oocytes resulted,
again, in an accelerated exit from the first meiosis, at 6–7 h af-
ter GVBD (Fig. 6 A; Table I), but had no effect on the
metaphase II arrest (Fig. 6 B; Table II). These results con-
firmed the previous results with the dominant-negative pro-
teins, suggesting that the CSF did not, at least not exclusively,
depend on either inhibitory Cdc20 phosphorylation nor a SAC-
mediated down-regulation of Cdc20, to prevent APC/C activa-
tion in mouse oocytes.
The mutant checkpoint proteins Bub1dn, BubR1d and
Mad2
 
 
 
C might exert their effect by interfering with Cdc20 lo-
calization. To test this hypothesis, we coinjected Cdc20-YFP
with Bub1dn, Mad2
 
 
 
C, or BubR1d. Bub1dn/Cdc20-YFP
doubly injected oocytes showed weak spindle localization of
Cdc20-YFP, but only a very weak signal from the kinetochores
throughout maturation, suggesting that Bub1 may be required
for kinetochore localization of Cdc20. A similar result was
found when BubR1d was coinjected, although the Cdc20-YFP
signal at the kinetochore was slightly stronger, especially dur-
ing first meiosis. On the other hand, Mad2
 
 
 
C did not affect
the localization of Cdc20 (Fig. 6 C). In addition, whereas the
Cdc20-4AV-YFP mutant localized to kinetochores like the
wild-type protein, Cdc20-GR-YFP was not detectable at kine-
tochores (Fig. 6 D).
 
Cdc20-4AVGR disrupts meiosis
 
Because the above results suggested that the two Cdc20 mu-
tants acted differently, we combined them to generate a double
mutant, Cdc20-4AVGR. This indeed had a synergistic effect
on the dominant behavior of Cdc20. When mRNA encoding a
Cdc20-4AVGR double mutant was injected into mouse oo-
cytes, the onset of anaphase of meiosis I was even earlier than
with any of our other mutant proteins, starting at 5–6 h after
GVBD (Fig. 7 A; Table I). However, despite the accelerated
entry into anaphase, the exit from meiosis I generally lasted
more than an hour (Fig. 7 A) and often could not be completed
properly. Some oocytes failed to extrude their PB, despite mul-
tiple attempts (Fig. 7 A, green box; the place where the PB
should be extruded is indicated by a yellow arrow), or pro-
duced two (Fig. 7 A, blue box; Table IV). When Cdc20-
4AVGR–injected oocytes were fixed after overnight culture,
and stained with PI and a tubulin-specific antibody, a variety of
phenotypes was revealed.
About 50% of the injected oocytes did not extrude their
first PB and the chromosomes were widely distributed on elon-
gated spindles (Fig. 7 B, b–d; Table IV). In some cases, two
spindles were connected to each other (Fig. 7 B, c) or two dif-
ferent types of spindles were observed, one monopolar, the
other a late telophase-like spindle (Fig. 7 B, d). Occasionally,
an interphase nucleus was observed (Fig. 7 B, e).
Oocytes that succeeded to extrude the first PB often ex-
hibited a disrupted meiotic spindle that only weakly stained
with antitubulin antibodies. Chromosomes were not properly
aligned at the metaphase plate (Fig. 7 B, f). About 5–10% of
the injected oocytes had two PBs extruded, and were arrested
(Fig. 7 B, g) with monopolar spindles. A quantification of these
results is shown in Table IV.
The Cdc20-4AVGR injected oocytes with anaphase-like
spindles and lagging chromosomes, or with two PBs extruded
(Fig. 7 B, f and g), seemed to have overcome the CSF arrest, al-
though their chromosomes were still condensed. To test,
whether the CSF was still active in Cdc20-4AVGR injected oo-
cytes, we treated them with strontium. This treatment induced
decondensation of the chromosomes, indicating an exit to inter-
phase from a metaphase II arrest (Fig. 7 C; Table III), thus ar-
guing against the hypothesis that the Cdc20-4AVGR mutant
overcame the CSF arrest.
 
Figure 7.
 
The effect of Cdc20-4AVGR injection into mouse oocytes.
 
 (A) Time-lapse video microscopy. Uninjected, or oocytes injected with the Cdc20-
4AVGR mutant were treated as in Fig. 3 A. Red arrows indicate the extruded PB. The oocyte marked by the green box failed, despite several attempts, to
extrude its PB. The pink arrow indicates the spot where the PB should have been extruded. The oocyte marked by the blue box, however, divided abnormally
and extruded two PBs, indicated by the light blue arrow. Time points (h) after GVBD are indicated. Bar, 50 
 
 
 
m. (B) Immunofluorescence staining of uninjected,
and Cdc20-4AVGR–injected oocytes. Oocytes were treated as in Fig. 4 B. (Left) The whole oocyte is shown in an overview. (Right) The area of the spindle
is enlarged, and the DNA and tubulin staining are shown individually, as well as overlaid (merge). The uninjected oocyte extruded the PB, and the chro-
mosomes are aligned on a metaphase plate with an intact spindle apparatus. Examples of the various phenotypes of Cdc20-4AVGR–injected oocytes are
shown below. In b–d, the oocytes did not extrude their first PB. The abnormal spindles in c and d are marked with red arrows. In e, an oocyte with an
interphase nucleus in the absence of any extruded PB is shown. In f, a typical example of an oocyte with one PB extruded is shown. In g, an oocyte is
shown with two extruded PBs. Bars, 10 
 
 
 
m. (C) Activation of Cdc20-4AVGR–injected oocytes. The oocytes were treated as in Fig. 4 C. The position of the
PB is marked. The oocyte nuclei are boxed, and shown enlarged in the insets. (D) Single cell H1/MBP kinase assay. Total H1 and MBP kinase activ-
ities were assayed in whole cell lysates prepared from uninjected, GV-stage, and Cdc20-, Cdc20-4AV–, and Cdc20-4AVGR–injected oocytes. The
autoradiograph is shown.
 
Table IV. 
 
Phenotypes observed with Cdc20-4AVGR–injected oocytes 
(
 
n
 
 
 
 
 
 159)
No PB extruded One PB extruded Two PBs extruded
cond.
 
a
 
decond.
 
b
 
cond. decond. chrom. cond.
 
%% % % %
 
37 12 45 0 6
 
a
 
Chromosomes condensed.
 
b
 
Chromosomes decondensed. 
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As an additional test, whether the above oocytes were
still arrested at metaphase II, MPF and MAPK activities
were assayed from individual uninjected, or Cdc20 wild-type,
Cdc20-4AV, or Cdc20-4AVGR mutant–injected oocytes. The
H1 kinase activity and MAPK activity from oocytes injected
with the double mutant, although slightly reduced in H1 kinase
activity when compared with the control oocytes, was readily
detectable (Fig. 7 D). Thus, the Cdc20-4AVGR–injected oo-
cytes were, despite their anaphase-like phenotype, still arrested
with high levels of Cdk activity. Together, with the fact that
strontium induced the decondensation of the chromosomes,
these results suggested that Cdc20-4AVGR–expressing cells
were still arrested by CSF.
 
The Cdc20-4AVGR mutant may induce 
sister chromatid separation in meiosis I
 
The anaphase-like spindles observed in the Cdc20-4AVGR–
injected cells might be the consequence of a premature separa-
tion of sister chromatids. To check for split sister chromatids,
chromosome spreads were prepared from uninjected, and
Cdc20-4AVGR–injected oocytes 16–18 h after GVBD.
The numbers of chromosomes from Cdc20-4AVGR–
injected oocytes clearly differed from those of their uninjected
counterparts (compare Fig. 8 A, b with c, d; a quantification is
shown in Fig. 8 B). In uninjected metaphase II oocytes, we
counted 18–24 chromosomes with 20 being the expected
number (Fig. 8 A b; Fig. 8 B). In Cdc20-4AVGR–injected oo-
cytes that had extruded a PB, chromosome counts were be-
tween 20 and 50 (Fig. 8 A, c and d; Fig. 8 B). The increase in
the number of chromosomes indicated that the sister chroma-
tids were at least partially separated in the Cdc20-4AVGR–
injected oocytes. The wide variation of counts, and the fact
that some were above the expected maximum of 40 chroma-
tids, suggested that chromosome mis-segregation had oc-
curred during meiosis I. Chromosomes prepared from Cdc20-
4AVGR–injected oocytes that had failed to extrude their PB
(Fig. 8 A, e and f) were not bivalent like those from control
oocytes in the first meiosis (Fig. 8 A, a). Chromosome counts
Figure 8. Cdc20-4AVGR mutant induces sister chromatid separation. (A) Chromosome spreads were prepared from noninjected, or Cdc20-4AVGR–
injected oocytes after overnight culture. The chromosomes were stained using a 2% Giemsa solution. In the insets, chromosomes are shown that were
found outside the main field. a, uninjected in 1st meiosis (6 h after GVBD); b, uninjected in 2nd meiosis; c and d, Cdc20-4AVGR–injected oocytes with the
PB extruded; e and f, Cdc20-4AVGR–injected oocytes with no PB extruded. Bar, 10  m. (B) Quantification of A. On the x axis are the numbers of chromo-
somes counted per oocyte, on the y axis the number of oocytes. a, control; b, Cdc20-4AVGR–injected oocytes with PB extruded; c, Cdc20-4AVGR–injected
oocytes with no PB extruded. (C) Time-lapse video microscopy. The Cdc20-4AVGR construct was coinjected into oocytes either with (a) cyclin B1N170-
RFP (a 170–amino acid NH2-terminal fragment of cyclin B1 fused to RFP) or with (b) Pds1-RFP. The oocytes were kept in dbcAMP for 1 h, released 4 h
after GVBD, and observed by differential interference contrast, and fluorescence time-lapse video microscopy. Pictures were taken every hour (BN170-RFP)
or every 45 min (Pds1-RFP). The complete series is shown. Time points (h) after GVBD are indicated. Bars, 50  m. 
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from these oocytes were higher than 40, ranging up to the
expected maximum of 80 (Fig. 8 B).
The observation that Cdc20-4AVGR–injected oocytes
could still be released from their anaphase-like arrest by stron-
tium, suggested that the activated Cdc20 mutant could either
not effectively turn on the APC/C in the presence of CSF, or
that cyclin B1 was selectively protected from proteolysis by
CSF. To investigate whether Cdc20-4AVGR was able to acti-
vate the APC/C, we measured the level of APC/C-dependent
proteolysis after the first meiosis in the presence of the acti-
vated mutant. As a proxy for destruction box- and APC/C-
dependent proteolysis, we monitored the fluorescence of a cy-
clin B1N170-RFP fusion construct, which comprises the cyclin
B1 NH
 
2
 
-terminal 170 aa including the destruction box, but
lacking the Cdk1 activation domain (King et al., 1995; Cohen-
Fix et al., 1996). The cyclin B1N170-RFP signal behaved as
a full-length cyclin B1-YFP fusion protein in mouse oocytes
(Ledan et al., 2001), accumulated until 7–8 h after GVBD and
disappeared before extrusion of the first PB. B1N170-RFP rap-
idly reaccumulated during meiosis II and was readily detect-
able in CSF-arrested control oocytes (Fig. 8 C, a, control).
In oocytes coinjected with Cdc20-4AVGR, B1N170-RFP
accumulated to lower levels and was degraded earlier after
GVBD, consistent with the more rapid progression through
meiosis I caused by the dominant Cdc20 mutant. Surprisingly,
however, B1N170-RFP reaccumulated during meiosis II to lev-
els in meiosis I, suggesting that CSF-mediated inhibition of the
APC/C could not be overcome by coexpression of Cdc20-
4AVGR (Fig. 8 C, a, Cdc20-4AVGR).
Similar results were obtained using a Pds1/securin-RFP
fusion protein, suggesting that the APC/C is refractory to
Cdc20 in the presence of CSF (Fig. 8 C, b). We concluded from
these experiments that expression of Cdc20-4AVGR caused
premature sister chromatid separation during meiosis I, as well
as an abnormal PB extrusion (cytokinesis), but failed to initiate
interphase between meiosis I and II and did not overcome the
CSF arrest in oocytes.
In summary, our data suggest that chromosome segrega-
tion during meiosis I is controlled by the SAC and that preco-
cious activation of the APC/C can cause premature sister chro-
matid separation during meiosis I. As oocytes progress into
meiosis II, CSF activation is dominant over the effects of con-
stitutively active Cdc20 mutants or dominant-negative interfer-
ing mutants of checkpoint proteins, suggesting that, in contrast
to frog oocytes, the SAC does not play an essential role in es-
tablishing or maintaining the CSF-dependent metaphase arrest
in meiosis II.
 
Discussion
 
Despite the discovery that the Mos–MAPK–p90
 
Rsk
 
 pathway is
essential and sufficient for CSF activity in 
 
Xenopus
 
 oocytes, lit-
tle is known about the downstream targets of this signal trans-
duction pathway. CSF activity acts by inhibiting the APC/C,
preventing sister chromatid separation and cyclin degradation.
The similarities between SAC-arrested cells and CSF-
arrested extracts suggested that the CSF might act via activation
of the SAC to inhibit the APC/C. Consistent with this hypothe-
sis, the SAC kinase Bub1 has been identified as a direct target
of the Mos–MAPK–p90
 
Rsk
 
 pathway in 
 
Xenopus
 
, highlighting a
potential role of the SAC in CSF. Further evidence that CSF
uses components of the SAC to inhibit the APC/C include the
notion that Mad2, as an inhibitor of Cdc20, is required for the
establishment of CSF (Tunquist et al., 2003), and that overex-
pression of Cdc20 could release 
 
Xenopus
 
 oocytes from the
meiosis II arrest (Reimann and Jackson, 2002).
In mouse oocytes, Mos is required to arrest cells at
metaphase of meiosis II. In contrast to Xenopus, however, Mos
deficiency does not allow the oocytes to proceed to interphase
between meiosis I or II. Rather, MPF activity remains high in
the majority of Mos-deficient oocytes, suggesting that cyclin
levels are controlled in a Mos-independent manner. Moreover,
if the integrity of the meiotic spindle is disrupted, mouse oo-
cytes are able to mount a potent SAC during meiosis I as well
as meiosis II, whereas additional nuclei have to be added to
frog egg extracts for a checkpoint arrest to be induced (Min-
shull et al., 1994). Thus, the checkpoint proteins involved in
the CSF arrest in frog egg extracts work in the absence of ki-
netochores. In the mouse oocyte, however, the SAC component
Bub1 localizes to kinetochores during metaphase of meiosis I
and II (Brunet et al., 2003).
To investigate the function of Bub1 during meiosis of
mouse oocytes, we overexpressed a dominant-negative mutant.
However, in contrast to the Xenopus system, we did not ob-
serve an exit from the CSF-mediated arrest at metaphase II.
Upon careful inspection, however, we discovered that chromo-
somes were not properly aligned at the metaphase plate in oth-
erwise apparently normal metaphase II arrested oocytes, sug-
gesting that the injected Bub1dn may have interfered with
some process in meiosis (unpublished data). Time-lapse video
microscopy of oocytes undergoing meiosis was used to mea-
sure the timing of meiotic events, which revealed that Bub1dn
caused an accelerated progression through meiosis I as indi-
cated by the earlier extrusion of the first PB.
Progression through meiosis I is controlled by the SAC in
mouse oocytes, as has been shown in experiments aimed to in-
vestigate the role of Mad2 during meiosis I (Wassmann et al.,
2003). Therefore, it is possible that the overexpression of
Bub1dn interfered with SAC function during meiosis I, causing
a precocious onset of anaphase, as has been observed in experi-
ments using human tissue culture cells (Taylor and McKeon,
1997; Geley et al., 2001).
In addition, Bub1dn was also able to disrupt the SAC
during meiosis II, which can be activated by nocodazole and
revealed by inactivating CSF using strontium. These data
strongly suggested that mouse oocytes are able to mount a
strong and Bub1 dependent SAC response during meiosis I and
II. Because the chromosomes are perfectly aligned during
metaphase of meiosis II, the conventional signal for SAC acti-
vation, i.e., chromosome misalignment, might be missing.
Nevertheless, Bub1 localizes to kinetochores (Fig. 2), and is
phosphorylated in CSF-arrested mouse oocytes (Brunet et al.,
2003) as in checkpoint-activated mitotic cells. But even if the
SAC was constitutively activated in meiosis II, it could beJCB • VOLUME 167 • NUMBER 6 • 2004 1048
overridden by Bub1dn without causing exit from meiosis, indi-
cating that the CSF-induced metaphase arrest is independent
from the SAC. This is in contrast to the frog system, in which
depletion of Bub1 interfered with the establishment of the
Mos-induced CSF arrest. However, because in this study, the
NH2 terminus of Bub1 (Bub1dn), believed to act as a dominant
negative by competing with the kinetochore localization of the
endogenous protein, was used, rather than depletion of the en-
dogenous protein, it is possible that Bub1dn did not interfere
with a kinetochore-independent function required for the estab-
lishment or maintenance of CSF. Due to the lack of suitable re-
agents, we have not investigated this possibility, but have pur-
sued the question of whether other SAC components might be
activated by the CSF during meiosis II to keep the APC/C in an
inactive state and prevent unwanted exit from meiosis II.
Mad2 and BubR1 are known to physically bind and
thereby inhibit the APC/C. Mad2 has been shown to localize at
kinetochores of the CSF-arrested mouse oocytes, suggesting
that the SAC might be active in meiosis II, or that the CSF
might induce a SAC-like state (Kallio et al., 2000). However,
none of the mutants tested by us overcame the CSF arrest, al-
though they efficiently interfered with the SAC in meiosis I
and II. We conclude from these experiments that the SAC can
be activated during meiosis I and II, and is essential for pro-
gression through meiosis I, but in meiosis II the oocytes be-
come arrested by CSF in a SAC-independent manner.
These results differ from observations using Xenopus egg
extracts. Xenopus egg extracts depleted of either of these check-
point proteins, could not be arrested by the addition of Mos, in-
dicating that these checkpoint proteins were necessary to estab-
lish the CSF arrest. However, in the same system, depletion of
most of the checkpoint proteins, except of Mad1, did not allow
the extract to exit from CSF. Even BubR1 and Mad2, as physi-
cal inhibitors of Cdc20, seemed dispensable once CSF was es-
tablished (Tunquist and Maller, 2003). However, in mouse oo-
cytes, a CSF arrest can be established and maintained even if
the function of the SAC components is disturbed by the overex-
pression of dominant negatives. Because it is currently not clear
how Mos regulates these checkpoint proteins to inhibit the
APC/C in CSF, and because our analysis was based on the use
of dominant-negative Bub1, Mad2, and BubR1, we could still
not exclude the possibility that the mutants only interfered with
the SAC function, but not with their putative function in CSF.
To go around this problem, we tested the effect of overex-
pressing wild type, and activated forms of the APC/C activator
Cdc20, the downstream target of the SAC, on CSF. In Xenopus
egg extracts, the addition of exogenous Cdc20-activated cyclin B
degradation and induced exit from mitosis in the absence of cal-
cium (Reimann and Jackson, 2002). Moreover, the expression of
a Cdc20-4AV mutant at levels comparable to endogenous
Cdc20 was able to mediate exit from CSF in Cdc20-depleted
frog egg extracts (Chung and Chen, 2003). These data suggest
that Cdc20 is the main target of CSF in frog meiosis and that it
may be inactivated by similar mechanisms in meiosis as during
SAC responses in mitosis. Neither wild-type, nor any of the acti-
vated Cdc20 mutants we tested overcame the CSF arrest, al-
though all of them interfered with the SAC in meiosis I and II.
The effect of the double mutant Cdc20-4AVGR, con-
structed to overcome currently known inhibitory pathways, is
difficult to explain. However, the apparently synergistic effect
of the two mutations suggested that, indeed, Cdc20 is con-
trolled by two independent pathways operative during meiosis.
Only Bub1dn, when expressed at very high levels, produced a
similar phenotype (unpublished data). Oocytes injected with ei-
ther mutant were arrested with anaphase-like spindles, some of
them in the absence of an extruded first PB. Furthermore, in the
case of Cdc20-4AVGR–injected oocytes, higher chromosome
counts were observed than in their uninjected counterparts, in-
dicating that interfering with APC/C regulation during meiosis
I might trigger premature sister chromatid separation. How-
ever, because neither Bub1dn nor Cdc20-4AVGR caused the
formation of interphase nuclei, it appears that APC/C control
was only relaxed for some, but not all targets, i.e., caused the
activation of separase (via Pds1/securin degradation), but to a
lesser extent the degradation of cyclin B1. This may be similar
to the situation in Xenopus CSF-arrested egg extracts, in which
cyclin B1 is stable, but cyclin A is barely detectable, and when
added as a recombinant protein, is rapidly degraded in a de-
struction-box–dependent manner (Geley et al., 2001).
Recently, sgo1 has been identified in yeast, and shown to
be essential for preventing cleavage of Rec8, the meiotic cohe-
sion, at centromeric regions during meiosis. Sgo1 is a substrate
of the APC/C, which becomes unstable only after meiosis I, al-
lowing equational chromosome segregation in meiosis I (Kita-
jima et al., 2004). The presence of homologous candidate genes
for Sgo1 in mammals suggests that a similar mechanism may
operate to control sister chromatid separation during meiosis of
mouse oocytes. The hyperactive Cdc20 might cause premature
degradation of Sgo1, resulting in the cleavage of Rec8, which
holds the sister kinetochores together.
However, even under these extreme conditions, which in-
duced sister chromatid separation during meiosis I, and this is
important for our main conclusion, CSF activity was induced
during further progression through meiosis, APC/C was shut
down, and the oocytes arrested at metaphase of meiosis II.
Thus, in mouse oocytes, the inhibition of the APC/C during the
second metaphase does not depend on the SAC.
Materials and methods
Preparation and culture of oocytes
Immature oocytes arrested at prophase of meiosis I were obtained from
ovarian follicles of ovaries removed from 8–12-wk-old FVB mice. They
were collected in M2 medium (Sigma-Aldrich) with 50  g/ml dbcAMP
(Sigma-Aldrich) to keep them at GV stage (the first prophase) under min-
eral oil at 37 C until injection. After injection, oocytes were washed with
and cultured in fresh M2 media to allow them to resume meiosis. No-
codazole was used at a final concentration of 10  M. Oocytes were re-
leased from CSF using 10 mM strontium (Sigma-Aldrich) in Ca
2 /Mg
2 -
free KSOM medium.
Plasmid construction
The Bub1dn cDNA was subcloned from pEF dnBub1. All other clones
were amplified by PCR from IMAGE clones as templates (BubR1:
IMAGp998F0810912Q2, Mad2: IMAGp998A206741Q3, Cdc20:
IMAGp998K2411151Q3, histone H2B: IMAGp998E0711102Q2), and
sequenced. To detect the expressed proteins, the cDNAs were then either
NH2-terminally double myc-tagged using the pBS KS 2myc vector, or fused
to either YFP (from pEFplmmB1-YFP) or RFP (from pCS2mRFP). For in vitroCSF IN MOUSE OOCYTES • TSURUMI ET AL. 1049
transcription reactions, cDNAs were cloned into either pRN3 (a gift from
M.-H. Verlhac, CNRS, Université Paris, Paris, France), which has a globin
3  UTR plus a short (30 A) poly A tail, or pBS-KC NBS 3  UTR, which has
the cyclin B1 3  UTR plus a 30 poly A tail.
RNA synthesis
The plasmids were linearized by SfiI (for pRN3) or SalI (for pBS-KC NBS
3  UTR) and purified using a gel extraction kit (QIAGEN). T3 message ma-
chine (Ambion) was used for producing capped mRNA, which was puri-
fied using the RNeasy kit (QIAGEN) and, if necessary, concentrated using
Microcon microconcentrators (Millipore).
Immunofluorescence and chromosome spreads
Immunofluorescence was performed as described previously (Polanski et
al., 1998), except that 4% PFA was used to fix the oocytes. The  -tubulin
specific YL1/2 rat mAb (CHEMICON International, Inc.) was used at a
dilution of 1/500 and developed using an FITC-conjugated  -rat IgG
(Santa Cruz Biotechnology, Inc.). Chromosome spreads were done ac-
cording to a previously described method (Clouston et al., 2002). Pic-
tures were taken using an AxioCam HRc (Carl Zeiss MicroImaging, Inc.)
mounted on an Axioplan microscope (Carl Zeiss MicroImaging, Inc.) with
40 /0.75 objective lenses.
Histone H1 kinase assay
Oocytes were collected in 1  l of a 5 mg/ml BSA solution, and frozen in
liquid N2. For the assay, 5  l of 2  H1 kinase buffer (40 mM Tris-HCl, pH
7.5, 160 mM  -glycerolphosphate, 40 mM EGTA, 30 mM MgCl2, 2 mM
DTT, 30  g/ml Leupeptin and pepstatin, 2 mM PMSF) and 1.5  l of water
were added to one oocyte. To start the reaction, 1.5  l of the reaction mix
(2 mg/ml histone H1 and MBP, 1 mM DTT, 15 mM MgCl2, 0.3 mM ATP,
5% (vol/vol)  -[
32P]ATP (10218; Amersham Biosciences) was added and
incubated at 37 C for 20 min. The reaction was stopped with 2  l 4  SDS
sample buffer, and the products were resolved using SDS-PAGE.
Microinjection and time-lapse video microscopy
GV stage oocytes were microinjected using an Eppendorf pressure micro-
injector and a 3D Hydraulic Coarse/Fine Micromanipulator mounted on a
microscope (model DM IRBE; Leica). For microinjections, 0.75 mg/ml (or
2 mg/ml for Mad2 C and Bub1dn high concentration) mRNA solutions
were used. 0.5  l mRNA was loaded into a borosilicate glass capillary
GC100TF-15 (Harvard Apparatus Ltd.) pulled out using a micropipette
puller. For time-lapse video microscopy, oocytes were cultured on a glass
bottom dish (WillCo) in an incubator for 3 h in a small drop of media un-
der mineral oil. They were then moved to an Axiovert 200M microscope
(Carl Zeiss MicroImaging, Inc.) with 20 /0.40 korr objective lenses
equipped with a 37 C heating box. AxioCam MRm or HRc cameras were
handled by the Axiovision 3.1 or 4 (Carl Zeiss MicroImaging, Inc.) soft-
ware package. Time-lapse series were generated by taking images at the
intervals indicated, and were subsequently converted to 8-bit images and
assembled in Adobe Photoshop.
The authors would like to thank Frieda Chen and Nicoletta Bobola for discus-
sions and critically reading the manuscript.
This work was in part supported by Austrian Science Fund (Fonds zur
Förderung der wissenschaftlichen Forschung) grant P15000 to S. Geley.
Submitted: 27 May 2004
Accepted: 5 November 2004
References
Basu, J., E. Logarinho, S. Herrmann, H. Bousbaa, Z. Li, G.K. Chan, T.J. Yen,
C.E. Sunkel, and M.L. Goldberg. 1998. Localization of the Drosophila
checkpoint control protein Bub3 to the kinetochore requires Bub1 but
not Zw10 or Rod. Chromosoma. 107:376–385.
Brunet, S., G. Pahlavan, S. Taylor, and B. Maro. 2003. Functionality of the spin-
dle checkpoint during the first meiotic division of mammalian oocytes.
Reproduction. 126:443–450.
Chan, G.K., B.T. Schaar, and T.J. Yen. 1998. Characterization of the kineto-
chore binding domain of CENP-E reveals interactions with the kineto-
chore proteins CENP-F and hBUBR1. J. Cell Biol. 143:49–63.
Chan, G.K., S.A. Jablonski, V. Sudakin, J.C. Hittle, and T.J. Yen. 1999. Human
BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at
kinetochores and binds the cyclosome/APC. J. Cell Biol. 146:941–954.
Chen, R.H., J.C. Waters, E.D. Salmon, and A.W. Murray. 1996. Association of
spindle assembly checkpoint component XMAD2 with unattached kine-
tochores. Science. 274:242–246.
Chung, E., and R.H. Chen. 2003. Phosphorylation of Cdc20 is required for its
inhibition by the spindle checkpoint. Nat. Cell Biol. 5:748–753.
Clouston, H.J., M. Herbert, J. Fenwick, A.P. Murdoch, and J. Wolstenholme.
2002. Cytogenetic analysis of human blastocysts. Prenat. Diagn. 22:
1143–1152.
Cohen-Fix, O., J.M. Peters, M.W. Kirschner, and D. Koshland. 1996. Anaphase
initiation in Saccharomyces cerevisiae is controlled by the APC-dependent
degradation of the anaphase inhibitor Pds1p. Genes Dev. 10:3081–3093.
Colledge, W.H., M.B. Carlton, G.B. Udy, and M.J. Evans. 1994. Disruption of
c-mos causes parthenogenetic development of unfertilized mouse eggs.
Nature. 370:65–68.
Dobles, M., V. Liberal, M.L. Scott, R. Benezra, and P.K. Sorger. 2000. Chro-
mosome missegregation and apoptosis in mice lacking the mitotic check-
point protein Mad2. Cell. 101:635–645.
Dunphy, W.G., L. Brizuela, D. Beach, and J. Newport. 1988. The Xenopus cdc2
protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell.
54:423–431.
Ferby, I., M. Blazquez, A. Palmer, R. Eritja, and A.R. Nebreda. 1999. A novel
p34(cdc2)-binding and activating protein that is necessary and suffi-
cient to trigger G(2)/M progression in Xenopus oocytes. Genes Dev.
13:2177–2189.
Furuno, N., M. Nishizawa, K. Okazaki, H. Tanaka, J. Iwashita, N. Nakajo, Y.
Ogawa, and N. Sagata. 1994. Suppression of DNA replication via Mos
function during meiotic divisions in Xenopus oocytes. EMBO J. 13:
2399–2410.
Gautier, J., C. Norbury, M. Lohka, P. Nurse, and J. Maller. 1988. Purified matu-
ration-promoting factor contains the product of a Xenopus homolog of
the fission yeast cell cycle control gene cdc2 . Cell. 54:433–439.
Geley, S., E. Kramer, C. Gieffers, J. Gannon, J.M. Peters, and T. Hunt. 2001.
Anaphase-promoting complex/cyclosome-dependent proteolysis of hu-
man cyclin A starts at the beginning of mitosis and is not subject to the
spindle assembly checkpoint. J. Cell Biol. 153:137–148.
Hashimoto, N., N. Watanabe, Y. Furuta, H. Tamemoto, N. Sagata, M. Yoko-
yama, K. Okazaki, M. Nagayoshi, N. Takeda, Y. Ikawa, et al. 1994. Par-
thenogenetic activation of oocytes in c-mos-deficient mice. Nature. 370:
68–71.
Hoyt, M.A., L. Totis, and B.T. Roberts. 1991. S. cerevisiae genes required for
cell cycle arrest in response to loss of microtubule function. Cell. 66:
507–517.
Kallio, M., J.E. Eriksson, and G.J. Gorbsky. 2000. Differences in spindle associ-
ation of the mitotic checkpoint protein Mad2 in mammalian spermatoge-
nesis and oogenesis. Dev. Biol. 225:112–123.
King, R.W., J.M. Peters, S. Tugendreich, M. Rolfe, P. Hieter, and M.W. Kirsch-
ner. 1995. A 20S complex containing CDC27 and CDC16 catalyzes the
mitosis-specific conjugation of ubiquitin to cyclin B. Cell. 81:279–288.
Kitajima, T.S., S.A. Kawashima, and Y. Watanabe. 2004. The conserved kine-
tochore protein shugoshin protects centromeric cohesion during meiosis.
Nature. 427:510–517
Ledan, E., Z. Polanski, M.E. Terret, and B. Maro. 2001. Meiotic maturation of
the mouse oocyte requires an equilibrium between cyclin B synthesis
and degradation. Dev. Biol. 232:400–413.
Li, R., and A.W. Murray. 1991. Feedback control of mitosis in budding yeast.
Cell. 66:519–531.
Li, Y., and R. Benezra. 1996. Identification of a human mitotic checkpoint gene:
hsMAD2. Science. 274:246–248.
Lohka, M.J., M.K. Hayes, and J.L. Maller. 1988. Purification of maturation-pro-
moting factor, an intracellular regulator of early mitotic events. Proc.
Natl. Acad. Sci. USA. 85:3009–3013.
Luo, X., Z. Tang, J. Rizo, and H. Yu. 2002. The Mad2 spindle checkpoint pro-
tein undergoes similar major conformational changes upon binding to ei-
ther Mad1 or Cdc20. Mol. Cell. 9:59–71.
Masui, Y., and C.L. Markert. 1971. Cytoplasmic control of nuclear behavior
during meiotic maturation of frog oocytes. J. Exp. Zool. 177:129–145.
Minshull, J., H. Sun, N.K. Tonks, and A.W. Murray. 1994. A MAP kinase-
dependent spindle assembly checkpoint in Xenopus egg extracts. Cell.
79:475–486.
Musacchio, A., and K.G. Hardwick. 2002. The spindle checkpoint: structural in-
sights into dynamic signalling. Nat. Rev. Mol. Cell Biol. 3:731–741.
Polanski, Z., E. Ledan, S. Brunet, S. Louvet, M.H. Verlhac, J.Z. Kubiak, and B.
Maro. 1998. Cyclin synthesis controls the progression of meiotic matura-
tion in mouse oocytes. Development. 125:4989–4997.
Reimann, J.D., and P.K. Jackson. 2002. Emi1 is required for cytostatic factor ar-
rest in vertebrate eggs. Nature. 416:850–854.
Sagata, N., M. Oskarsson, T. Copeland, J. Brumbaugh, and G.F. Vande Woude.JCB • VOLUME 167 • NUMBER 6 • 2004 1050
1988. Function of c-mos proto-oncogene product in meiotic maturation
in Xenopus oocytes. Nature. 335:519–525.
Sagata, N., N. Watanabe, G.F. Vande Woude, and Y. Ikawa. 1989. The c-mos
proto-oncogene product is a cytostatic factor responsible for meiotic ar-
rest in vertebrate eggs. Nature. 342:512–518.
Schott, E.J., and M.A. Hoyt. 1998. Dominant alleles of Saccharomyces cerevisiae
CDC20 reveal its role in promoting anaphase. Genetics. 148:599–610.
Schwab, M.S., B.T. Roberts, S.D. Gross, B.J. Tunquist, F.E. Taieb, A.L. Lewel-
lyn, and J.L. Maller. 2001. Bub1 is activated by the protein kinase
p90(Rsk) during Xenopus oocyte maturation. Curr. Biol. 11:141–150.
Sharp-Baker, H., and R.H. Chen. 2001. Spindle checkpoint protein Bub1 is re-
quired for kinetochore localization of Mad1, Mad2, Bub3, and CENP-E,
independently of its kinase activity. J. Cell Biol. 153:1239–1250.
Tang, Z., R. Bharadwaj, B. Li, and H. Yu. 2001. Mad2-Independent inhibition
of APCCdc20 by the mitotic checkpoint protein BubR1. Dev. Cell.
1:227–237.
Taylor, S.S., and F. McKeon. 1997. Kinetochore localization of murine Bub1 is
required for normal mitotic timing and checkpoint response to spindle
damage. Cell. 89:727–735.
Taylor, S.S., E. Ha, and F. McKeon. 1998. The human homologue of Bub3 is
required for kinetochore localization of Bub1 and a Mad3/Bub1-related
protein kinase. J. Cell Biol. 142:1–11.
Tunquist, B.J., P.A. Eyers, L.G. Chen, A.L. Lewellyn, and J.L. Maller. 2003.
Spindle checkpoint proteins Mad1 and Mad2 are required for cytostatic
factor-mediated metaphase arrest. J. Cell Biol. 163:1231–1242.
Tunquist, B.J., and J.L. Maller. 2003. Under arrest: cytostatic factor (CSF)-
mediated metaphase arrest in vertebrate eggs. Genes Dev. 17:683–710.
Tunquist, B.J., M.S. Schwab, L.G. Chen, and J.L. Maller. 2002. The spindle
checkpoint kinase bub1 and cyclin e/cdk2 both contribute to the estab-
lishment of meiotic metaphase arrest by cytostatic factor. Curr. Biol.
12:1027–1033.
Verlhac, M.H., J.Z. Kubiak, M. Weber, G. Geraud, W.H. Colledge, M.J. Evans,
and B. Maro. 1996. Mos is required for MAP kinase activation and is in-
volved in microtubule organization during meiotic maturation in the
mouse. Development. 122:815–822.
Wassmann, K., T. Niault, and B. Maro. 2003. Metaphase I arrest upon activa-
tion of the Mad2-dependent spindle checkpoint in mouse oocytes. Curr.
Biol. 13:1596–1608.
Weiss, E., and M. Winey. 1996. The Saccharomyces cerevisiae spindle pole
body duplication gene MPS1 is part of a mitotic checkpoint. J. Cell Biol.
132:111–123.
Yew, N., M.L. Mellini, and G.F. Vande Woude. 1992. Meiotic initiation by the
mos protein in Xenopus. Nature. 355:649–652.
Yu, H. 2002. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin.
Cell Biol. 14:706–714.
Zhou, J., J. Yao, and H.C. Joshi. 2002. Attachment and tension in the spindle as-
sembly checkpoint. J. Cell Sci. 115:3547–3555.